Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2023-12-04 6:2:56 am | NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity | BusinessWire |
| 2023-11-28 6:0:0 am | NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan | Business Wire |
| 2023-11-21 5:30:0 am | NanoVibronix Regains Nasdaq Compliance | Business Wire |
| 2023-11-14 5:30:0 am | NanoVibronix Issues Letter to Shareholders | Business Wire |
| 2023-11-07 5:30:0 am | NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1 | Business Wire |
| 2023-09-27 5:0:0 am | NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff | Business Wire |
| 2023-09-06 5:30:0 am | NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting | Business Wire |
Please consider a small donation if you think this website provides you with relevant information